Your browser doesn't support javascript.
loading
Correction to: Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing's syndrome.
Geer, Eliza B; Salvatori, Roberto; Elenkova, Atanaska; Fleseriu, Maria; Pivonello, Rosario; Witek, Przemyslaw; Feelders, Richard A; Bex, Marie; Borresen, Stina W; Puglisi, Soraya; Biller, Beverly M K; Cohen, Fredric; Pecori Giraldi, Francesca.
  • Geer EB; Memorial Sloan Kettering Cancer Center, New York, NY, USA. geere@mskcc.org.
  • Salvatori R; Johns Hopkins University, Baltimore, MD, USA.
  • Elenkova A; Medical University Sofia, Sofia, Bulgaria.
  • Fleseriu M; Oregon Health and Science University, Portland, OR, USA.
  • Pivonello R; Università Federico II di Napoli, Naples, Italy.
  • Witek P; Department of Internal Diseases, Endocrinology and Diabetes, Medical University of Warsaw, Warsaw, Poland.
  • Feelders RA; Erasmus Medical Center, Rotterdam, The Netherlands.
  • Bex M; University Hospitals Leuven, Leuven, Belgium.
  • Borresen SW; Department of Medical Endocrinology and Metabolism, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Puglisi S; Department of Clinical and Biological Sciences, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Italy.
  • Biller BMK; Massachusetts General Hospital, Boston, MA, USA.
  • Cohen F; Strongbridge Biopharma, Trevose, PA, USA.
  • Pecori Giraldi F; Department of Clinical Sciences & Community Health, University of Milan, Milan, Italy.
Pituitary ; 24(1): 116, 2021 Feb.
Article en En | MEDLINE | ID: mdl-33313999

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Año: 2021 Tipo del documento: Article